Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Warner

Showing results (531-540 of 551) with videos related to

Pageof 56
Sort By:
Bioresource Technology|April 29, 2011
Comparative material balances around pretreatment technologies for the conversion of switchgrass to soluble sugarsRebecca J Garlock, Venkatesh Balan, Bruce E Dale, et al.
Bioresource Technology|May 17, 2011
Surface and ultrastructural characterization of raw and pretreated switchgrassBryon S Donohoe, Todd B Vinzant, Richard T Elander, et al.
Science Immunology|October 17, 2025
Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse modelsZhenfei Xie, Xuesong Wang, Yu Yan, et al.
Science Immunology|May 16, 2024
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse modelsXuesong Wang, Christopher A Cottrell, Xiaozhen Hu, et al.
Global Change Biology|April 27, 2022
Coral-bleaching responses to climate change across biological scalesRobert van Woesik, Tom Shlesinger, Andréa G Grottoli, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trialM P Goetz, N A Bagegni, G Batist, et al.
Gastrointestinal Endoscopy|January 25, 2024
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patientsYinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Pageof 56

Showing results (531-540 of 551) with videos related to

Sort By:
Pageof 56
Bioresource Technology|April 29, 2011
Comparative material balances around pretreatment technologies for the conversion of switchgrass to soluble sugarsRebecca J Garlock, Venkatesh Balan, Bruce E Dale, et al.
Bioresource Technology|May 17, 2011
Surface and ultrastructural characterization of raw and pretreated switchgrassBryon S Donohoe, Todd B Vinzant, Richard T Elander, et al.
Science Immunology|October 17, 2025
Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse modelsZhenfei Xie, Xuesong Wang, Yu Yan, et al.
Science Immunology|May 16, 2024
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse modelsXuesong Wang, Christopher A Cottrell, Xiaozhen Hu, et al.
Global Change Biology|April 27, 2022
Coral-bleaching responses to climate change across biological scalesRobert van Woesik, Tom Shlesinger, Andréa G Grottoli, et al.
Journal of Medical Genetics|July 5, 2005
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesA C Antoniou, P D P Pharoah, S Narod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trialM P Goetz, N A Bagegni, G Batist, et al.
Gastrointestinal Endoscopy|January 25, 2024
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patientsYinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, et al.
Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Pageof 56